Korean Drug Co., Ltd. (KOSDAQ:014570)

Korean Drug Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	46,158	50,141	78,348	85,441	97,444	112,394
Market Cap Growth	-15.57%	-36.00%	-8.30%	-12.32%	-13.30%	43.25%
Enterprise Value	20,912	30,087	41,605	53,950	71,749	92,548
Last Close Price	4230.00	4595.00	6935.57	7403.88	8254.97	9339.95
PE Ratio	12.88	16.74	-	7.24	10.78	15.27
PS Ratio	0.74	0.69	0.96	1.07	1.31	1.68
PB Ratio	0.58	0.64	1.02	1.01	1.27	1.59
P/TBV Ratio	0.58	0.64	1.02	1.01	1.27	1.60
P/FCF Ratio	5.17	13.05	-	-	12.72	9.70
P/OCF Ratio	4.74	10.30	-	14.45	11.07	9.12
EV/Sales Ratio	0.33	0.41	0.51	0.68	0.96	1.39
EV/EBITDA Ratio	3.86	4.87	4.91	3.43	5.63	7.47
EV/EBIT Ratio	6.14	7.33	6.19	3.77	6.37	8.38
EV/FCF Ratio	2.34	7.83	-	-	9.37	7.98
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.01	0.01	0.01	0.01	0.00	0.00
Debt / FCF Ratio	0.01	0.02	-	-	0.01	0.00
Asset Turnover	0.69	0.82	0.88	0.87	0.87	0.84
Inventory Turnover	1.71	2.01	2.74	3.41	3.67	3.37
Quick Ratio	5.53	5.81	4.52	7.81	5.51	5.13
Current Ratio	7.94	8.73	6.41	9.80	6.82	6.44
Return on Equity (ROE)	4.53%	3.86%	-6.08%	14.63%	12.26%	10.83%
Return on Assets (ROA)	2.33%	2.87%	4.56%	9.78%	8.19%	8.67%
Return on Capital (ROIC)	2.71%	3.30%	5.19%	11.09%	9.54%	10.14%
Return on Capital Employed (ROCE)	4.10%	5.00%	8.40%	16.50%	14.40%	15.00%
Earnings Yield	7.69%	5.97%	-6.28%	13.82%	9.28%	6.55%
FCF Yield	19.35%	7.66%	-2.71%	-0.21%	7.86%	10.31%
Payout Ratio	48.75%	54.02%	-	15.52%	18.07%	14.80%
Buyback Yield / Dilution	-0.22%	-0.08%	0.01%	1.30%	-0.56%	0.33%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.